Recording summary · September 2023
NEW Investors: DO THIS NOW to Unlock Massive Profits
AI-generated reading aids, not verified accounts.
These summaries describe what appears in the transcripts. A speaker’s claims are not established facts, and transcription or speaker-label errors can carry through. Check the linked transcripts and original recordings for context.
Months and years group recording metadata—not necessarily when an event happened. Undated recordings remain separate.
Read this recording’s transcript →
Overview
Daniel reviews an investment portfolio covering stock picks for 2023 and 2024, noting that the discussion is not financial advice.
The portfolio gained nearly £600 over the past month, rising from £10,000 to £10,600.
Top portfolio holdings include Barrick Gold, an inverse S&P 500 ETF, China Growth, an emerging markets dividend ETF, and Bellevue Healthcare, aligned with defensive positioning against US macroeconomic risks.
Barrick Gold represents the largest holding with 351 shares worth £4,700 as a hedge against inflation, stagflation, and dollar weakness, while the second-largest position is an inverse S&P 500 fund split between an ISA and a GIA in anticipation of a market downturn.
Positions in China Growth and an emerging markets dividend ETF provide diversification and upside potential following drops linked to the Chinese housing market, while Bellevue Healthcare is held as a defensive position expected to gain once tech euphoria subsides.
A technical pattern and possible weak sales of the iPhone 15 could trigger a substantial fall in Apple shares and pull down the wider US market.
A healthcare holding with a 4.35% dividend yield offset a 6% price decline through dividends, while a restructured JPMorgan Emerging Europe, Middle East, and Africa fund delivered a 60% gain and 34% dividend yield after recovering from a steep drop caused by the Ukraine conflict.
Gold, inverse positions, and China are projected to perform well over the next six to twelve months as US market euphoria fades and Apple meets resistance.
Themes
Review of Daniel's portfolio holdings, recent recovery, and monthly performance gains.
Defensive allocations including Barrick Gold and inverse S&P 500 funds aimed at hedging macroeconomic risks and an anticipated market downturn.
Exposure to China and emerging markets following declines tied to the Chinese property sector.
Healthcare sector holdings and their performance and dividend returns.
JPMorgan Emerging Europe, Middle East, and Africa fund restructuring and recovery following losses in Russian securities.
Market outlook regarding potential declines in Apple, broader US market vulnerability, and expectations for gold and inverse positions.
Developments
Daniel's portfolio value increased from £10,000 to £10,600 over the past month.
Daniel purchased Russian securities prior to a nearly 100% loss in value resulting from the conflict in Ukraine.
JPMorgan restructured its Russian securities ETF into a fund concentrated on emerging Europe, the Middle East, and Africa.
Uncertainties & gaps
The exact identity of the 1980s figure who raised interest rates close to 20% is remembered uncertainly as Paul or a similar name.
The exact timing and scale of an expected stock market crash remain uncertain, with timing possibly near the end of the month or year.
Future economic stimulus measures and quantitative easing by China remain anticipated expectations rather than confirmed events.
Whether the healthcare stock will drop further is uncertain, though stabilization or an increase from its current level is viewed as more likely.
The future performance of gold, inverse funds, and China over the next 6 to 12 months remains uncertain as it depends on an expected downturn in Apple and the wider US market.